Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine
Clinical trial NCT02648425 · COMPLETED
Trial details
- NCT number
- NCT02648425
- Sponsor
- ASLAN Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-05
- Primary completion
- 2017-06-12
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.